Your browser doesn't support javascript.
loading
Impact of COVID-19 prevention measures on Clostridioides difficile infections in a regional acute care hospital.
Sipos, Simona; Vlad, Cristian; Prejbeanu, Radu; Haragus, Horia; Vlad, Daliborca; Cristian, Horia; Dumitrascu, Cristian; Popescu, Roxana; Dumitrascu, Victor; Predescu, Vlad.
Afiliación
  • Sipos S; Department of Pharmacology, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.
  • Vlad C; Department of Pharmacology, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.
  • Prejbeanu R; Department of Orthopedics and Trauma, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.
  • Haragus H; Department of Orthopedics and Trauma, Premiere Hospital, 300643 Timisoara, Romania.
  • Vlad D; Department of Orthopedics and Trauma, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.
  • Cristian H; Department of Pharmacology, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.
  • Dumitrascu C; Department of Surgery II, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.
  • Popescu R; Department of Cardiovascular Surgery, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.
  • Dumitrascu V; Department of Cell and Molecular Biology, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.
  • Predescu V; Department of Pharmacology, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.
Exp Ther Med ; 22(5): 1215, 2021 Nov.
Article en En | MEDLINE | ID: mdl-34584560
ABSTRACT
Clostridioides difficile (C. difficile) is a common cause of nosocomial diarrhea. The multi-modal infection control strategies designed to contain the COVID-19 pandemic have had an unintended positive effect on other hospital-acquired infections. The aim of the present study was to analyze the impact of the COVID-19 prevention measures on healthcare-associated C. difficile infections in a large regional acute care center. Electronic databases were reviewed from the start of the pandemic (March) up to November 2020. Average values from the same months from 2019 and 2018 were used as controls. Using the ICD-10 discharge coding, 65 C. difficile cases per 25,124 patients were identified in 2020 compared to 151/43,126 from the 2018 and 2019 averages (P=0.0484). The C. difficile cases were found to be decreased after the implementation of COVID-19 infection control strategies compared to previous years, despite an increase in antibiotic use. Subset analysis during lockdown showed a clear decrease but the difference was not statistically significant. For the months of recovery after lockdown, the number of cases was comparable to previous years.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Exp Ther Med Año: 2021 Tipo del documento: Article País de afiliación: Rumanía

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Exp Ther Med Año: 2021 Tipo del documento: Article País de afiliación: Rumanía